Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 201 entries
View as:

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06186427 Org: User:
Start: 01/13/24 End: 12/31/25 Due: 12/31/26

Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02822326 Org: User:
Start: 01/31/16 End: 09/30/19 Due: 09/30/20

Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy

Phase: N/A Priority: Normal
NCT ID: NCT06024980 Org: User:
Start: 01/03/23 End: 12/01/25 Due: 12/01/26

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00600587 Org: User:
Start: 09/30/07 End: 06/30/13 Due: 06/30/14

Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06550765 Org: User:
Start: 08/25/24 End: 12/31/27 Due: 12/31/28

Aggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT02067195 Org: User:
Start: 07/31/14 End: 07/31/17 Due: 07/31/18

The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.

Phase: N/A Priority: Normal
NCT ID: NCT02710747 Org: User:
Start: 01/31/15 End: 07/31/16 Due: 07/31/17

Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02194075 Org: User:
Start: 10/31/13 End: 10/31/15 Due: 10/31/16

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination with Chemotherapy for Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06758544 Org: User:
Start: 12/12/24 End: 11/30/26 Due: 11/30/27

Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells

Phase: N/A Priority: Normal
NCT ID: NCT02291770 Org: User:
Start: 10/31/14 End: 12/31/19 Due: 12/31/20

DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03154749 Org: User:
Start: 09/01/16 End: 12/31/19 Due: 12/31/20

Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04637308 Org: User:
Start: 09/01/19 End: 09/30/20 Due: 09/30/21

ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Phase: N/A Priority: Normal
NCT ID: NCT04381143 Org: User:
Start: 07/30/20 End: 12/31/26 Due: 12/31/27

Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06771960 Org: User:
Start: 02/01/25 End: 12/30/25 Due: 12/30/26

Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00614809 Org: User:
Start: 12/31/07 End: 12/31/10 Due: 12/31/11

Sub-total Parathyroidectomy Reduces Vascular Calcification in Haemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01140490 Org: User:
Start: 01/31/09 End: 12/31/11 Due: 12/31/12

Multi-omics Study of Clinical Endpoints in CHD

Phase: N/A Priority: Normal
NCT ID: NCT03797339 Org: User:
Start: 07/01/17 End: 12/31/20 Due: 12/31/21

Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT05272696 Org: User:
Start: 03/01/22 End: 01/01/25 Due: 01/01/26

S-ADHF：Sarcopenia in Patients With ADHF

Phase: N/A Priority: Normal
NCT ID: NCT06298825 Org: User:
Start: 04/01/24 End: 06/01/26 Due: 06/01/27

Induction Lorlatinib in Stage III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05740943 Org: User:
Start: 03/15/23 End: 12/31/26 Due: 12/31/27

Organoid-based Functional Precision Therapy for Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06102824 Org: User:
Start: 10/01/24 End: 06/30/28 Due: 06/30/29

A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06825975 Org: User:
Start: 02/12/25 End: 12/31/26 Due: 12/31/27

Efficacy of Triple-Combination Therapy in Severe PAH-CHD

Phase: N/A Priority: Normal
NCT ID: NCT06196801 Org: User:
Start: 06/17/22 End: 12/01/25 Due: 12/01/26

Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)

Phase: N/A Priority: Normal
NCT ID: NCT04858529 Org: User:
Start: 04/30/21 End: 04/30/25 Due: 04/30/26

Neuroimaging Study of N-acetylcysteine in Excoriation (Skin-Picking) Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06956157 Org: User:
Start: 06/22/22 End: 08/13/25 Due: 08/13/26